Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.00
Bid: 60.00
Ask: 80.00
Change: -5.00 (-6.67%)
Spread: 20.00 (33.333%)
Open: 75.00
High: 75.00
Low: 70.00
Prev. Close: 75.00
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Pre-close Trading Statement

24 Jan 2019 07:00

RNS Number : 9387N
Biome Technologies PLC
24 January 2019
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR")

 

24 January 2019

 

Biome Technologies plc

("Biome", "the Company" or "the Group")

 

Pre-close Trading Statement

 

 

Biome Technologies plc, a leading bioplastics and radio frequency technology business, today provides a pre-close trading statement for the financial year ended 31 December 2018.

 

Group revenues for the year were £8.8m, a 42% increase on the 2017 revenues of £6.2m.

 

The Group made an increased profit before interest, tax, depreciation, amortisation, and share option charges ("EBITDA") for the year compared to the prior year period (based on unaudited management accounts).

 

The Group's cash position as at 31 December 2018 was £2.6m (31 December 2017: £2.3m).

 

The preliminary results for the year ended 31 December 2018 are scheduled to be published on 28 March 2019.

 

Bioplastics Division

Revenues in the Bioplastics division for the year ended 31 December 2018 were £1.9m, a 17% reduction on the previous year (2017: £2.3m).

 

Over the last year, sales of the non-woven filter mesh for the US single serve coffee market have increased, together with other revenues, by more than 50%, compared to the prior year, in line with our strategy to diversify the customer base. The overall drop in annual Bioplastics revenues throughout the year is due to significantly lower sales of outer packaging for the US single serve coffee market.

 

As shareholders are aware, we continue to build a more diverse and extensive portfolio of bioplastics applications with new and existing customers, many of which are expected to contribute substantially to sales, particularly in the latter part of 2019. These include the rigid ring project for the coffee market that continues through its testing phase and is now expected to contribute to sales in Q2 2019 (rather than Q1 2019 as previously indicated); disposable cutlery for the US market which is designed to meet much higher user performance standards; a novel material for a single served pod being launched into the nutrition market; and a plastic film based product for the North American market. Customers' interaction and engagement with these projects is high.

 

Whilst the opportunities described above are all located in North America, the focus on the broader issue of plastic pollution in the UK has generated increased local market interest. Potential opportunities of scale are gradually emerging as brands and businesses adjust to this environment.

 

Stanelco RF Technologies Division

Revenues in the RF Technologies division for the year ended 31 December 2018 were £7.0m (2017: £4.0m), a 75% increase on the previous year.

 

Very strong demand in the fibre optic furnace market for Far Eastern markets has been the prime driver of the increase in sales in 2018. Whilst enquiry levels remain encouraging for 2019, the firm order book now is, at present, lower than the comparative period in 2018. Whilst greater visibility is expected in the coming months, it is anticipated, at present, that 2019 revenues in this division will be higher than those seen in the year to 31 December 2017, but lower than the exceptional year to 31 December 2018.

 

Outlook

As 2019 unfolds, we expect a gradual but substantial increase in Bioplastics revenues. This trend should be encouraging for investors and should reward their patient support for our development of new materials in an area of outstanding business potential. RF Technologies' revenues are expected to continue to reflect the nature of this cyclical business area.

 

 

- Ends -

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

 

 

 

About Biome

Biome Technologies plc is an AIM listed, growth-orientated, commercially driven technology group. Our strategy is founded on building market-leading positions based on patented technology and serving international customers in valuable market sectors. We have chosen to do this by developing products in application areas where the value-added pricing can be justified and that are not reliant on government legislation. These products are driven by customer requirements and are compatible with existing manufacturing processes. They are market rather than technology-led.

The Group comprises two divisions, Biome Bioplastics Limited and Stanelco RF Technologies Limited. Biome Bioplastics is a leading developer of highly-functional, bio-based and biodegradable plastics. The company's mission is to produce bioplastics that challenge the dominance of oil-based polymers. Stanelco RF Technologies designs, builds and services advanced radio frequency (RF) systems. Dielectric and induction heating products are at the core of a product offering that ranges from portable sealing devices to large furnaces for the fibre optics markets.

In 2018, the Board has adopted the following three high level KPIs for the next three years to continue its ambitious momentum:

· Compound revenue growth of 25% per annum across the Group and 40% compound revenue growth in the Bioplastics division

· Diversify the Group's turnover by product and market to ensure that no one product or end customer contributes more than 15% of revenues by 2020

· Increase investment in the Group's next generation of products by spending significantly more per annum on average than the £0.3m per annum average spend over the previous strategic objective cycle

 

www.biometechnologiesplc.com

www.biomebioplastics.com and www.thinkbioplastic.com

www.stanelcorftechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKXLFLKFFBBBD
Date   Source Headline
29th Apr 20247:01 amRNSTrading Update
29th Apr 20247:00 amRNSFinal Results 2023
15th Mar 20247:00 amRNSContract win for Stanelco RF Division
11th Mar 20241:59 pmRNSIssue of Convertible Loan Notes, PDMR Notification
15th Feb 20242:54 pmRNSContract win for RF Division
6th Feb 20247:00 amRNSTrading Update
13th Nov 20237:00 amRNSTrading Update
10th Oct 20234:32 pmRNSGrant of Options
27th Sep 20237:00 amRNSInterim Results
26th Jul 20237:00 amRNSTrading Update
30th Jun 20235:00 pmRNSTotal Voting Rights
22nd Jun 20237:00 amRNSContract win for Stanelco RF Division
31st May 20237:00 amRNSIssue of Equity, Director/PDMR Shareholding & TVR
25th May 20232:57 pmRNSAppointment of Non-Executive Director
25th May 202312:45 pmRNSResult of AGM
2nd May 20231:05 pmRNSDirector/PDMR Shareholding
27th Apr 20237:00 amRNSNotice of AGM and 2022 Annual Report
26th Apr 20237:01 amRNSTrading Update
26th Apr 20237:00 amRNSFinal Results 2022
18th Apr 202310:49 amRNSCompletion of CLN Fundraising
17th Apr 202311:30 amRNSResult of General Meeting
31st Mar 202311:14 amRNSProposed issue of Convertible Loan Notes
25th Jan 20237:00 amRNSTrading Update
16th Nov 20227:00 amRNSBiome receives £282k grant
10th Nov 202211:05 amRNSSecond Price Monitoring Extn
10th Nov 202211:00 amRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTrading Update
18th Oct 20229:28 amRNSHolding(s) in Company
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
22nd Sep 20222:05 pmRNSSecond Price Monitoring Extn
22nd Sep 20222:00 pmRNSPrice Monitoring Extension
22nd Sep 20229:05 amRNSSecond Price Monitoring Extn
22nd Sep 20229:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
5th Sep 20227:00 amRNSGrant funding from Innovate UK
2nd Aug 20228:59 amRNSTrading Update - Replacement
2nd Aug 20227:00 amRNSTrading Update
20th Apr 202212:01 pmRNSResult of Annual General Meeting
20th Apr 20227:00 amRNSTrading Update
30th Mar 20222:48 pmRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSNotice of AGM and 2021 Annual Report
24th Mar 20227:00 amRNSFinal Results 2021
27th Jan 20227:00 amRNSTrading Update
4th Jan 202210:33 amRNSFurther substantial contract win for RF Division
16th Dec 20218:41 amRNSContract
17th Nov 20217:00 amRNSTrading Update
9th Nov 202111:12 amRNSHolding(s) in Company
25th Oct 20217:00 amRNSUpdate re biodegradable tree shelters
15th Sep 20217:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.